HOME > TOP STORIES

TOP STORIES

BUSINESS NBI Initiates PIII Study for BIBF1122 in Japan

September 12, 2011
REGULATORY MHLW Director-General Kikura Indicates “Firm Resolve” for Structural Improvement to Eliminate Drug Disasters

September 12, 2011
ACADEMIA Clinical Positioning Needs to Be Clarified for Nexavar, Sutent: Prof. Naito of Kyushu Univ.

September 12, 2011
REGULATORY MHLW’s Council to Draw Up 10-Year Strategy for Hepatitis

September 9, 2011
REGULATORY Council Recommends Subsidization of Peginterferon Therapy for Chronic Active Hepatitis B

September 9, 2011
BUSINESS Eisai to Accelerate Clinical Development with Milestone Payments, Signs Agreement on PIII Trials for Lenvatinib

September 8, 2011
REGULATORY CSIMC Introduces New Rule for Pricing of High-Priced Drugs; 10 Drugs to Be Reimbursed on Piecework under DPC

September 8, 2011
REGULATORY Some CSIMC Members Question NHI Pricing of Nexium Priced at Lower Level Than Omepral

September 8, 2011
REGULATORY CSIMC Recommends NHI Price Listing for 15 APIs/20 Products

September 7, 2011
ACADEMIA ”Seller’s Market” for Pharmacists Expected to Continue Over Next Few Years

September 7, 2011
ORGANIZATION JGA to Prepare Transparency GLs

September 6, 2011
ORGANIZATION Gaining Piece of the Pie in Growing Market “Best for Fast Results”: Keizai Doyukai’s Hasegawa

September 6, 2011
REGULATORY Pharmaceutical Industry Fully Sufficient as Export Industry: METI Minister Hachiro

September 5, 2011
REGULATORY MHLW Minister Komiyama to Focus on Social Security Reform

September 5, 2011
REGULATORY Noda Cabinet: MHLW Vice Minister Komiyama Promoted to Minister

September 5, 2011
BUSINESS Daiichi Sankyo Espha Asks Patent Office to Invalidate Combination Patents for Takeda’s Actos

September 2, 2011

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s Biological Raw Material Rules Enter Major Revision; Clarity on Benefits and Safety Holds Key

By Sakura Kono

Japan is poised to make the most sweeping revision in eight years to the Standards for Biological Raw Materials —…

COLUMN

AI in Healthcare Hiring: Leveling the Playing Field & Unlocking Human Potential

By Philip Carrigan

The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…